NXG · NexgenRx Inc.
AI read · Good for NXG
The AI's read
The tax charge followed the use of the company's remaining past tax losses. That bill caused the reported loss, but sales and profit measures rose in Q3 and across the first 9 months.
NexgenRx grew sales and profit measures in Q3 and over the first 9 months. A $907,728 tax charge caused a $63,993 loss, but the reported business gains support improvement.
The tax charge followed the use of the company's remaining past tax losses. That bill caused the reported loss, but sales and profit measures rose in Q3 and across the first 9 months.
Follow NexgenRx Inc. (NXG) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for NXG